Are Sex Toys FDA Approved? What FDA's Own Record Says

By Alex Hart · Last updated 2026-08-10

On 10 August 2026, the first organic result Google returned in the United States for the question are sex toys FDA approved was a shop aisle captioned as though they are. The page is a Target category listing, its heading reads “FDA-Approved : Vibrators & Adult Toys”, and it is open to search engines (Target category page, retrieved 10 Aug 2026). Seven positions below it, at number eight, sat the record the answer starts from: FDA’s own device classification for the code these products fall under.

Research-based, not hands-on (how we review) · This page carries no affiliate links, and nothing below was shown to any manufacturer before publication · We may earn a commission on Lovense products through our app-controlled vibrator guide; the full list of programmes we are in is on our disclosure page

Quick take: no, and two different words fail for two different reasons. FDA’s classification record under product code KXQ puts genital vibrators for therapeutic use in Device Class 2, with the Submission Type listed as 510(k) Exempt. Approved belongs to the premarket approval pathway, which part 814 applies to class III devices, so it was never available to a Class 2 device at all. Cleared would have come from the 510(k) review, which this class is exempt from for devices of the ordinary kind, under a limitation covered below. So there is no approval for a product in this class to hold, and in the ordinary case no clearance either. The strongest true claim left is FDA-registered, which says a filing exists and nothing more.

There is also a prior question that decides which half of that answer is even about you. FDA’s rule reaches a device only if it is intended and labelled for therapeutic use, so a product sold purely for pleasure sits outside 884.5960 altogether and answers to ordinary consumer product law instead.

What FDA’s own record actually says

FDA maintains a public product classification database. The record for product code KXQ, retrieved on 10 August 2026, reads as follows (FDA Product Classification, product code KXQ):

Two of those rows do most of the work, and they point in opposite directions. Keeping both in view at once is the whole of the answer.

The underlying regulation is short. 21 CFR 884.5960 defines the device as “an electrically operated device intended and labeled for therapeutic use in the treatment of sexual dysfunction or as an adjunct to Kegel’s exercise”, then classifies it as “Class II (performance standards)” and states that “the device is exempt from the premarket notification procedures in part 807, subpart E, of this chapter subject to the limitations in § 884.9” (eCFR, 21 CFR 884.5960, retrieved 10 Aug 2026). The rule dates to February 1980 and was last amended in June 2018.

That closing clause is easy to read past, and it matters. Section 884.9 makes the exemption conditional rather than categorical: it holds “only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type”. A manufacturer must still file a premarket notification where the device “is intended for a use different from the intended use of a legally marketed device in that generic type”, or where “the modified device operates using a different fundamental scientific technology than a legally marketed device in that generic type” (eCFR, 21 CFR 884.9, retrieved 10 Aug 2026). So the exemption covers the ordinary case, not every case. It is the preamble that does most of that work: a device without the “existing or reasonably foreseeable characteristics” of what is already sold does not sit inside the exemption to begin with, and one sold for a new medical purpose goes back through the review it would otherwise skip.

Part 884 contains neighbouring entries for related products, and their titles show the qualifier is not applied uniformly. The entry at 884.5940 is a powered vaginal muscle stimulator for therapeutic use, carrying the same wording. The one at 884.5970, a clitoral engorgement device, is not titled that way, and we did not read its defining text to see what conditions it instead (eCFR, 21 CFR Part 884 Subpart F, retrieved 10 Aug 2026). What follows is about 884.5960, the entry that governs vibrators.

The label, not the object, decides whether the rule applies

Read the definition again and notice which words are doing the work: intended and labeled for therapeutic use. Jurisdiction attaches to the claim the manufacturer makes, not to the physical device. Two identical objects can sit on either side of the line depending on what the box says.

That is not a loophole anyone has to infer. Researchers publishing in Sexual Medicine Reviews in 2023 describe the practice directly, writing that manufacturers “avoid regulation under FDA medical device jurisdiction by including ‘for novelty use only’ on labels, implying that the product is intended as a ‘gag gift’ with no practical use”, and that companies “currently use labels such as ‘for novelty use only’, with the result being they avoid FDA regulation as medical devices” (Sipe et al., Sexual Medicine Reviews, 23 Mar 2023).

So the phrase that looks like legal boilerplate on the underside of a package is the mechanism. A device marketed for pleasure carries no therapeutic claim, so it falls outside 884.5960 and is not regulated as a medical device. What governs it instead is the ordinary consumer product regime.

Registered, cleared, and approved are three different claims

These get used interchangeably in marketing copy, and the gap between them is where a shopper gets misled. Each one has a regulation behind it, and the regulations do not agree with the marketing.

Registered means a company has listed itself and its devices with FDA. It is an administrative filing, and FDA’s own rule is blunt about what it does not imply: “Registration of a device establishment or assignment of a registration number does not in any way denote approval of the establishment or its products.” The same section goes further, stating that “any representation that creates an impression of official approval because of registration or possession of a registration number is misleading and constitutes misbranding”. Its title is Misbranding by reference to establishment registration or to registration number (eCFR, 21 CFR 807.39, retrieved 10 Aug 2026).

Cleared means FDA reviewed a premarket notification, the 510(k), and agreed the device is substantially equivalent to something already on the market. That is a real review, and it is exactly the procedure that 884.5960 exempts this class from by name, part 807 subpart E, for devices whose characteristics are already on the market. Under 884.9 a novel one still has to file.

Approved is a different and higher pathway. Part 814 sets out “procedures for the premarket approval of medical devices” and states that it “applies to any class III medical device” (eCFR, 21 CFR 814.1, retrieved 10 Aug 2026). Genital vibrators for therapeutic use are Device Class 2. Approval is not a road this class travels.

The practical consequence is that the strongest true statement available to a compliant manufacturer here is the weakest sounding one. A vendor page that appeared on the same results page put it precisely: “MV devices are FDA-registered Class II therapeutic vibrators (21 CFR §884.5960, product code KXQ)”, adding that they are “not cleared or approved for the treatment of any other condition” (MysteryVibe, retrieved 10 Aug 2026). That wording cites the regulation, names the product code, and stops where the evidence stops. It is the model for how the claim should read, and it is notable that a company selling the product stated the position more carefully than the aisle caption ranking above it. What we checked here is the wording, not the filing behind it: FDA’s establishment registration database was not consulted, so treat this as an example of careful phrasing rather than as confirmation that any particular device is registered.

To be fair to the retailer, a page like that is faceted navigation rather than written editorial, and some companies whose products appear under it may well be registered with FDA. How the attribute behind the facet gets set is not something we established, and in any case it would change who is answerable for the wording rather than whether the wording is right. Neither point rescues the word approved, which names a pathway a Class 2 device does not travel. Note also what 807.39 is and is not about: it governs a manufacturer trading on its own registration, so it speaks to the FDA-registered claim rather than to a retailer’s category caption. It is quoted above to show that FDA treats the distance between registration and approval as consequential rather than pedantic, not to characterise any particular listing.

What this does not mean

The opposite error is just as common, and page one contains it too. The answer box Google displayed for this query states that these products “are not FDA approved or regulated”, which is half right (Contemporary OB/GYN, 1 Apr 2024). The first half is correct. The second overshoots.

The same FDA record that says 510(k) exempt also says GMP Exempt: No. Registered manufacturers remain subject to the Quality System Regulation, which governs how a device is designed and produced. General consumer product law still applies on top of that, and a hazardous product can still trigger the reporting duties and enforcement described below. Registration is a genuine obligation with genuine consequences for ignoring it.

Notice, though, which of those three the earlier point narrows, because it is only one of them. The Quality System Regulation reaches manufacturers that registered, and a company ends up registered because it made a therapeutic claim that pulled it inside 884.5960 to begin with. A product labelled for novelty use is outside that rule, so its maker has no occasion to appear on that list and the design-and-production obligation never attaches. The other two strands are untouched by any of this, because neither runs through FDA registration. A product outside 884.5960 sits with the general consumer product regime, and that regime is not empty. 16 CFR part 1115 sets out the Consumer Product Safety Commission’s interpretation of the reporting duties that section 15(b) of the Consumer Product Safety Act places on manufacturers, importers, distributors and retailers, and states that it also exists “to indicate the actions and sanctions which the Commission may require or impose to protect the public from substantial product hazards” (eCFR, 16 CFR 1115.1, retrieved 10 Aug 2026). What that regime does not contain is a standard written for these products in particular, which is the gap the legal scholarship quoted below argues about. Which track a given product sits on is decided by the same thing that decides everything else here. If a listing makes no therapeutic claim and cites no regulation number, the sensible assumption is that its maker is not registered, because that is precisely what the label is asking for.

So what is absent is narrower and more specific than “regulation”. For an ordinary device inside 884.5960, one the exemption covers, no person at an agency examined that particular device before it went to market. For one outside it, FDA’s medical-device rules were never the applicable ones, which leaves the general consumer product regime and nothing device-specific layered on top. Either way the gap is a review gap rather than a lawlessness gap, and the distinction matters because it tells you what to substitute.

Legal scholarship has been arguing the point for some time. A 2025 note in the Columbia Journal of Law & Social Problems frames it as a double gap, observing that the Consumer Product Safety Commission “has no specific regulatory standards for sex devices, regulating them as ‘novelty toys’”, while FDA “unnecessarily limits its oversight by only regulating ‘therapeutic’ sex devices” (Columbia Journal of Law & Social Problems, 29 May 2025). That piece argues for expanding FDA authority, so it is advocacy rather than a neutral description of the law. Its FDA half matches the primary documents quoted above. We did not independently check its characterisation of CPSC, and no inventory of CPSC standards is cited here.

What carries information instead

Two different things have just been taken away, and they are worth keeping apart. The marketing adjectives carry no regulatory meaning at all. Registration status carries some, but only that a filing exists. Neither tells you whether this device was examined, so something else has to.

The named material beats any safety adjective. The US phthalate restriction lives in 16 CFR Part 1307, titled “Prohibition of Children’s Toys and Child Care Articles Containing Specified Phthalates”, and its scope is children’s products (eCFR, 16 CFR Part 1307, retrieved 10 Aug 2026). Adult products are outside it, which makes body-safe an unregulated marketing term. A manufacturer willing to name the polymer is giving you something checkable; one that offers only an adjective is not. We go through what the named materials actually differ on in our guide to body-safe materials.

Published testing beats self-description. The same 2023 paper tested four products, identifying each material by ATR-FTIR and analysing the extracts by GC-MS. Its result, in the authors’ own words, is that “phthalates known to be endocrine disruptors were present in all tested sex toys at levels exceeding hazard warnings”. That set included the item the same analysis identified as a silicone blend, which the authors had picked partly because its packaging claimed “medical grade silicone”, and which “contained the greatest number of individual phthalates with 7 different phthalates detected but at low concentrations”. The beads and the dual vibrator each carried only one, di-n-octyl phthalate, but “at concentrations higher than the 0.1 weight % allowed in children’s toys by US regulatory agencies”. Across the set, the authors report that “all four sex toys contained phthalates that are either over the 0.1 weight % limit (for DnOP) or banned under REACH” in the EU, so a low concentration did not mean below every threshold. Four items cannot rank materials against one another and the paper does not attempt it. What the silicone result does show is that the adjective on the box did not mean an absence of phthalates. The authors also state their own limit: “This data set is not intended to be representative of sex toys as an entire class of products, nor are the abrasion experiments claiming to simulate exact use conditions.” Read it as a reason to distrust an unsupported safety adjective, not as a measurement of any product you own.

For connected devices, the companion software is outside 884.5960’s scope. Nothing in 884.5960 touches what a companion app collects or how an account is secured. Those are covered in our review of sex toy app safety.

Common questions

Can any sex toy legitimately claim FDA approval? Not within this class, and for two separate reasons. Approval comes from the premarket approval pathway, which part 814 applies to class III devices; product code KXQ is Device Class 2, so that route was never open to it. Clearance comes from the 510(k), and KXQ’s submission type is 510(k) Exempt, so for an ordinary device of this type that review does not happen either. The exemption is not unconditional: under 884.9 a device intended for a different use, or a modified one working by a different fundamental technology than what is already marketed, still has to file. Neither word is available in the ordinary case, and they are unavailable on different grounds.

Is a company lying if it says FDA-registered? Not necessarily, but the wording is only safe with its limit attached. Registration is a real filing that a company either made or did not, so the bare fact can be true. What 807.39 forbids is letting that fact create an impression of official approval, which it calls misleading and treats as misbranding. Phrased with the limit attached, in the shape the vendor wording quoted above takes, it is a fair claim about what a filing means. Phrased bare, with nothing beside it, it does the work the rule is aimed at.

Does the exemption mean the device was never checked at all? For the devices the exemption covers, it means FDA did not check before sale. If the maker is registered, the classification record’s “No” to GMP Exempt means its own quality obligations still apply. If the product is labelled for novelty use, the maker has no occasion to be registered and that obligation never attaches, leaving the general consumer product regime. For an in-class device the exemption covers, that is a review which did not take place; a device that falls outside the exemption under 884.9 does file one. For the out-of-class case there was no FDA review step to miss to begin with.

Which claims on a listing are worth anything? The ones that are checkable: a named material, a named regulation with a number, a published test with a method. Adjectives such as body-safe, medical grade, and hospital grade have no regulatory definition for these products, so they carry the weight of the company’s own reputation and nothing more.